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a  b  s  t  r  a  c  t
Lupus requires careful treatment by medical specialists. This study aimed to evaluate the
quality of life of patients living with Systemic Lupus Erythematosus (SLE). The method
approached women with a conﬁrmed diagnosis of SLE under medical supervision in a Uni-
versity hospital outpatient clinic or in a private clinic. We used an instrument containing
relevant information of the patient and also the Portuguese version of the World Health Orga-
nization Quality of Life Group (WHOQOL-100) questionnaire. The study population consisted
of  39 women, married in their majority (56.4%); prevalently aged 37–60 years old; prevalence
of  diagnosis time over ﬁve years (66.7%); and in use of less than 5 medications (69.2%).
92.3% had the disease inactive with higher means in mobility (p = 0.0463) and quality of
life  (p = 0.0199) facets; on the other hand, the physical safety and security facet (p = 0.0093)
showed higher mean for people with active disease. Health and social care analysis showed
availability and quality (p = 0.0434), even when with other associated diseases (33.3%); and
the  highest means were Dependence on medicinal substances and medical aids (p = 0.0143).
The  negative results for associated diseases were higher in sexual activity (p = 0.0431) and
transportation (p = 0.0319) facets. In conclusion: if women living with SLE receive continuous
medical attention, they will enjoy good quality of life, while minimizing the complications
inherent in this condition.
© 2015 Elsevier Editora Ltda. All rights reserved.
Inﬂuência  da  atenc¸ão médica  na  qualidade  de  vida  (WHOQOL-100)
de  mulheres  com  lúpus  eritematoso  sistêmico
r  e  s  u  m  oPalavras-chave:
Lúpus eritematoso sistêmico
Qualidade de vida
Assistência ao paciente
O lúpus exige tratamento cuidadoso por médicos especialistas. Este estudo teve como
objetivo avaliar a qualidade de vida de pacientes com lúpus eritematoso sistêmico (LES).
O  método abordou mulheres com diagnóstico conﬁrmado de LES sob acompanhamento
médico em ambulatório de hospital escola ou particular. Usou-se instrumento que continha
informac¸ões relevantes do paciente e a versão em português do instrumento de pesquisa
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World Health Organization Quality of Life Group (WHOQOL-100). A populac¸ão estudada per-
fez 39 mulheres, na sua maioria casadas (56,4%); com idade prevalente de 37 a 60 anos; tempo
de  diagnóstico prevalente maior de cinco anos (66,7%); uso de menos de cinco medicamen-
tos  (69,2%). Obteve-se que 92,3% estavam com a doenc¸a controlada com médias maiores
nas  facetas mobilidade (p = 0,0463) e qualidade de vida (p = 0,0199). Já a faceta seguranc¸a
física e protec¸ão (p = 0,0093) apresentou média maior para pessoas com a doenc¸a em estado
ativado. As análises de cuidados de saúde e sociais apresentaram disponibilidade e qual-
idade (p = 0,0434) mesmo com outras patologias associadas (33,3%) e as maiores médias
foram dependência de medicac¸ão ou de tratamentos (p = 0,0143). Os resultados negativos
para  doenc¸a associada foram maiores nas facetas atividade sexual (p = 0,0431) e transporte
(p  = 0,0319). Conclui-se que se a mulher com LES receber atenc¸ão médica de forma continua
apresentará qualidade de vida que minimizará as complicac¸ões inerentes a essa patologia.
© 2015 Elsevier Editora Ltda. Todos os direitos reservados.
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ystemic lupus erythematosus (SLE) is an autoimmune
hronic disease with highest incidence in the age group from
5 to 40 years old.1 SLE affects 10 times more  women than
en, its treatment varies according to the type and sever-
ty of symptoms and, due to its complex nature, this disease
equires active participation of the patient to maintain a sat-
sfactory level of health. SLE has a poor prognosis, but the
dvancement of therapeutic possibilities has provided better
uality of life (QoL) for people living with this disease.2
Being a chronic disease, SLE has a prevalent psychosomatic
imension, and it is important to consider the stress and the
sychosocial suffering on its onset, evolution, aggravation and
otential control. This disease requires an interdisciplinary
ntervention for its care, in addition to considering the pecu-
iar way with which the disease is expressed in the life of every
ndividual, as the psychosocial aspects contribute to the com-
lexity of the development and exacerbation of symptoms.3
The effect of the changes caused by the disease process
nd its treatment in the clinical course of the disease demand
easures that favor QoL as a critical instrument of satisfaction
or patients and health professionals. In people with SLE, a
ecrease of QoL occurs compared with the general population.
his QoL loss is due to physical and emotional changes caused
y the disease process, especially in periods of exacerbation
f SLE.1
QoL can be understood as consisting of three factors:
ubjective well-being, which refers to the perception of the
ndividual, his/her values and beliefs; health, understood as a
tate of physical, mental and social well-being and not merely
s the absence of disease; and thirdly, social well-being, which
efers to the situation of the person in relation to his/her envi-
onment and society.4
The assessment of QoL for women with SLE can be
s important as the measurement of their morbidity and
ortality,5 focusing on the ability to live without disease
r overcoming difﬁculties stemmed from morbid states or
6onditions.
In many  cases, the difﬁculty in understanding the etiology
nd the pathophysiological process related to this difﬁcult to
iagnose disease prevents its speciﬁc treatment.7The assessment of QoL in these patients is an essential
element so that one can get an idea of the impact of the disease
and its treatment in a distinct and complementary way, which
contributes to a better care of patients and their families in
the emotional distress management, and also facilitates the
experience with a disease that is painful, chronic and often
disabling.
This study was conducted with the aim to evaluate QoL
of patients living with SLE medically treated in the City of
Maringa, State of Parana, aiming to qualify the associated fac-
tors and their interference in QoL, with speciﬁc contributions
to this area of knowledge.
Patients  and  methods
This is a cross-sectional study involving women with estab-
lished SLE, aged over 18 years, seen at a Rheumatology private
clinic and at a university hospital outpatient clinic located in
Maringa, Parana. For inclusion in the study, the women must
have had an appointment frequency of at least once a year,
with medical follow-up, regardless of the nature of the point
of care.
The number of participants was delimited based on the
access to patients and on their agreement to participate in
the study, and also by their regularity in attendance to medical
care for at least once a year.
After signing the Informed Consent Form in agreement
with the study, the patient had scheduled the place and date
for completion of the study questionnaires; or the completion
of the questionnaires was carried out when the woman was
approached, after obtaining her written consent.
In the study, the patients completed a self-reported
instrument, without interference from the researcher. The
evaluation was structured in two parts: Part 1. A questionnaire
for assessment of clinical and socio-demographic data, includ-
ing age, education, marital status, occupation, number of
working hours per day, family income, housing, disease onset,
physical activity, tobacco and alcohol use, drugs used and
associated diseases; Part 2. Application of the World Health
Organization Quality of Life (WHOQOL-100) questionnaire –
Portuguese version.
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Table 1 – Characterization of socio-demographic data of
women with SLE, City of Maringa.
Sample characterization n %
Marital status
Married 22 56.4
Divorced 4 10.3
Single 12 30.8
Widow 1 2.6
Age group
18–24 12 30.8
25–36 11 28.2
37–60 14 35.9
More than 60 years 2 5.1
Education
Primary complete 6 15.4
High School complete 21 53.8
University degree incomplete 6 15.4
University degree complete 1 2.6
Post-graduate complete 5 12.8
Daily workload
Up to 6 h 4 10.3
8–9 h 12 30.8
10–12 h 8 20.5
Does not work/not reported 15 38.5
Income
2 Salaries 5 12.8
3 Salaries 14 35.9
More than 3 salaries 19 48.7
Not reported 1 2.6
Housing
Rented 7 17.9
Home ownership 31 79.5
Lives with
Family 35 89.7
Other people 1 2.6
Alone 2 5.1
Not reported 1 2.6
Smoking
Not 38 97.4
Yes 1 2.6
Alcoholism
Not 35 89.7200  r e v b r a s r e u m a t
The World Health Organization Quality of Life Group
(WHOQOL-100) questionnaire is a generic QoL instrument
drawn up in 1998 by the World Health Organization (WHO)
based on a multicenter study. WHOQOL-100 contains ques-
tions that address the following areas: physical health (pain,
discomfort, energy and fatigue, sleep and rest); psychological
(positive feelings, thinking, learning, memory,  concentra-
tion, self-esteem, body image  and physical appearance, and
negative feelings); independence level (mobility, daily activi-
ties, dependence on medicinal substances and medical aids
and working capacity); social relationships (personal rela-
tionships, social support and sexual activity); environmental
(physical safety and security, home environment, ﬁnan-
cial resources, health care, social care, recreation/leisure,
physical environment and transportation) and spiritual
aspects/religion/personal beliefs (spirituality, religion, per-
sonal beliefs).
The results of WHOQOL-100 are expressed through scores
assigned for each facet and domain. For obtaining these
scores, descriptive statistics of each item were held for the
following elements: mean, standard deviation, and minimum
and maximum values.8 To assess QoL, it was decided that the
closer from 100 was the sum of the scores of the domains, the
better the quality of life; the reverse is true.
Data were computed in Microsoft Excel spreadsheet soft-
ware  (2010). For statistical analysis, the tool provided by
Pedroso et al. (2011),8 based on Microsoft Excel software, was
used. This instrument performs calculations resulting from
the WHOQOL-100 application, according to the syntax pro-
posed by the WHO  WHOQOL Group. Non-paired t-tests for
domains and facets were performed, always considering as
reference the statistical programs Statistica 8.0 and SAS Sys-
tem 9.1.
The project was evaluated and approved by CESUMAR
Ethics Committee (CEP-CESUMAR), according to certiﬁcate No.
106/2011 and protocol No 122/2011.
Results
The study population consisted of 39 female patients; most
were married (56.4%) and the prevalent age group was that of
37–60 years old (35.9%), followed by 18–24 years old (30.8%).
This group had a good educational level: 84.6% reported 11
years or more  of study. With respect to social support, 30.8%
work 8–9 h/day, and 20.5% work 10–12 h/day; an income of
three or more  minimum wages  were prevalent (84.6%) in the
group. As for housing, 79.5% were homeowners and 89.7%
were living with family members. About reported habits, 97.4%
did not use tobacco and 89.7% did not use alcohol (Table 1).
At the time of the interview, 92.3% had their disease in
a controlled state and 7.7% exhibited an active disease. For
most women (66.7%), the diagnosis had been established
over 5 years ago, and most (69.2%) used less than 5 medica-
tions. 33.3% of participants reported other associated diseases.
Comparing the domains of QoL (WHOQOL-100) with the
time elapsed since the diagnosis of SLE, the highest mean
(17.5 ± 2.6) score was obtained for Spiritual aspects domain,
and the lowest mean (12.9 ± 2.9) was found for Independence
level. With regard to total scores (QoL), patients with less thanYes 4 10.3
5 years elapsed since the diagnosis of SLE had better quality of
life (87.3) versus those with more  than 5 years (82.2). In the set-
ting of a statistical signiﬁcance of 5%, no difference was found
between the means for patients, regarding the time elapsed
since the diagnosis of SLE (Table 2).
Table 3 depicts the correlation between the mean of QoL
domains (WHOQOL-100) with the total number of medications
used daily by the patient, irrespective whether for SLE or not.
The greatest scoring mean was obtained for spiritual aspects
domain (16.9 ± 2.4) and the lowest mean for physical domain
(12.8 ± 2.8). It is noteworthy that the number of medications
used inﬂuences the quality of life: the use of less than ﬁve
medications had a total of 86.0, and more  than ﬁve medica-
tions, 84.9. The mean for domains of patients taking more  than
ﬁve medications did not differ from the mean for domains
r e v b r a s r e u m a t o l . 2 0 1 6;5 6(3):198–205 201
Table 2 – Comparison of quality of life domains and facets (WHOQOL-100) related to the time of diagnosis, City of
Maringa.
Domains/facets Diagnosis time pa
>5 years (n = 27) <5 years (n = 13)
Mean SD Mean SD
Physical health 13.2 2.9 12.0 2.5  0.2081
Pain and discomfort 12.6 3.8 13.9 3.0 0.2766
Energy and fatigue 12.5 4.2 11.5 3.9 0.5144
Sleep and rest 15.6 3.9 14.2 3.9 0.3042
Psychological 13.8 2.3 12.9 2.3 0.3066
Positive feelings 15.2 2.7 14.6 2.8 0.5473
Thinking, learning, memory and concentration 14.0 3.2 13.2 2.4 0.4489
Self-esteem 14.8 2.8 13.3 2.6 0.1137
Body image and appearance 12.9 3.2 11.6 4.2 0.3141
Negative feelings 12.1 2.9 12.1 2.9 0.9999
Independence level 12.9 2.9 12.6 3.1 0.7766
Mobility 14.6 4.3 14.2 3.8 0.8033
Activities of daily living 14.2 3.9 12.8 3.9 0.3059
Dependence on medicinal substances and medical aids 16.2 3.5 14.2 4.2 0.1103
Work capacity 15.0 4.2 13.7 3.3 0.3320
Social relations 15.6 2.4 14.4 2.8  0.1791
Personal relationships 15.8 2.6 14.9 3.0 0.3688
Social support 16.5 2.8 15.5 3.3 0.3302
Sexual activity 14.5 4.2 12.8 3.4 0.2184
Environment 14.5 2.1 14.1 1.8 0.5838
Physical safety and security 12.6 2.1 12.9 1.5 0.6807
Home environment 15.7 2.4 14.9 2.8 0.3159
Financial resources 13.0 3.5 13.5 3.0 0.6603
Health and social care: availability and quality 14.5 2.6 13.9  1.9 0.4275
Opportunities to acquire new information and skills 15.3 3.2 15.4 3.0 0.9190
Participation in. and opportunities for recreation/leisure 13.9 3.9 13.5 2.6 0.7983
Physical environment: (pollution/noise/trafﬁc/climate) 14.1 2.4 12.4 2.9 0.0527
Transportation 16.7 3.1 16.4 3.2 0.8011
Spiritual aspects/spirituality/religion/personal beliefs 17.5 2.6 16.2 1.6 0.1169
Quality of life from the point of view of the evaluated subject 14.7 2.7 13.9 2.7 0.4088
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a Non-paired t  test.
f patients taking less than ﬁve medications (5% signiﬁcance
evel).
Table 4 shows the comparison between groups for active
r inactive disease, where the highest mean score belongs to
piritual/Religion/Personal Beliefs aspects (16.7 ± 1.2) and the
owest for independence level (10.3 ± 3.8), and the means of
omains both for patients with active versus inactive disease
id not differ, at a 5% signiﬁcance level.
With respect to the individual analysis of facets, it was
ound that in people with inactive disease their means
ere higher for mobility (p = 0.0463) and quality of life facets
eported by the interviewee (p = 0.0199), while for physical
afety and security facet (p = 0.0093) the group with active dis-
ase (Table 4) had a higher mean.
It was observed that QoL is better for those patients with
isease remission (86.1) versus those with active disease (80.5).
 signiﬁcant difference (p < 0.05) for the means of the analyzed
omains was not evidenced (Table 4).
As to diseases associated with SLE, six patients reported
aving another disease(s): one of the interviewees reportedmore  than one condition, quoting osteoarthritis, osteoporo-
sis, and ﬁbromyalgia; and the others, only one condition for
each: bronchitis, anemia, hypertriglyceridemia, antiphospho-
lipid syndrome, and drug-induced hepatitis.
Table 5 shows the means for the comparison of groups
with respect to diseases associated, with higher scores for
the environment (13.8 ± 1.9). The mean for independence level
domain differs when patients with versus without associated
diseases were compared, with means of 11.1 ± 2.4 vs.13.6 ± 2.9
(p = 0.0102), respectively, considering the signiﬁcance level of
5%.
In the analysis of facets, with respect to the reference of
associated diseases, it was found that the mean of afﬁrmative
references was higher for medication or treatment depend-
ency facet (p = 0.0143). The negative references were higher
in Sexual activity (p = 0.0431) and transportation (p = 0.0319)
facets.When comparing the total of mean values (QoL) for asso-
ciated diseases, it becomes clear that those patients who
reported not being carriers had higher QoL (87.7) versus those
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Table 3 – Comparison of quality of life domains and facets (WHOQOL-100) related to the amount of medications taken,
City of Maringa.
Domains/facets Number of medications pa
Less than 5 (n = 27) More than 5 (n = 12)
Mean SD Mean SD
Physical health 12.8 2.8 12.7 3.0  0.8966
Pain and discomfort 13.3 3.7 12.4 3.4 0.4760
Energy and fatigue 12.4 4.2 11.7 3.9 0.6196
Sleep and rest 15.3 4.0 14.8 3.9 0.6432
Psychological 13.5 2.6 13.4 1.7 0.8540
Positive feelings 15.2 3.0 14.7 2.2 0.6091
Thinking, learning, memory and concentration 13.6 3.4 14.2 1.7 0.5434
Self-esteem 14.3 3.1 14.3 2.1 0.9331
Body image and appearance 12.6 3.6 12.2 3.6 0.7498
Negative feelings 12.0 2.6 12.3 3.5 0.7074
Independence level 13.0 3.3 12.3 2.0 0.5173
Mobility 14.1 4.6 15.3 2.6 0.4090
Activities of daily living 13.9 4.0 13.3 3.9 0.6995
Dependence on medicinal substances and medical aids 14.8 4.3 17.3 1.5 0.0523
Work capacity 14.8 3.9 14.0 4.0 0.5474
Social relations 15.3 2.8 14.9 2.1  0.6508
Personal relationships 15.5 2.9 15.5 2.4 0.9831
Social support 16.2 3.3 15.9 2.2 0.7688
Sexual activity 14.2 4.0 13.3 4.2 0.4946
Environment 14.5 2.2 14.0 1.3 0.4677
Physical safety and security 13.0 1.8 11.9 2.0 0.0933
Home environment 15.7 2.8 14.8 1.9 0.3165
Financial resources 13.3 3.5 13.1 2.8 0.8730
Health and social care: availability and quality 14.8 2.2 13.2  2.4 0.0434b
Opportunities to acquire new information and skills 15.3 3.7 15.3 1.4 0.9401
Participation in. and opportunities for recreation/leisure 13.5 3.8 14.3 2.9 0.4776
Physical environment: (pollution/noise/trafﬁc/climate) 13.7 2.4 13.3 3.3 0.6473
Transportation 16.7 3.4 16.2 2.3 0.5892
Spiritual aspects/spirituality/religion/personal beliefs 16.9 2.4 17.6 2.4 0.3834
Quality of life from the point of view of the evaluated subject 14.3 3.1 14.7 1.5 0.7119
SD, standard deviation.
a Non-paired t test.
b Signiﬁcant considering a signiﬁcance level of 5%.
who  reported comorbidity (81.6). The analyzed patients had
total mean values above 80 in all aspects analyzed, meaning
a good quality of life.
Discussion
The quality of life questionnaires provide a more  complete
assessment of the impact of disease and of treatment in the
patients’ daily life.9
With regard to diagnosis, a higher mean for independence
level was found. A diagnosis with deﬁnition of pathology
represent a time when life can undergo signiﬁcant changes,
depending of the speciﬁcs of the disease and the symptoms
experienced, besides the need to control and/or minimize the
recurrence of these symptoms.Araújo and Traverso-Yépez (2007)3 suggested that most
women ﬁnd it difﬁcult to face such a diagnosis, and most of
them express a sense of shock, centered on the ﬁnding of a dis-
ease that has no cure. When evaluating patients followed ina rheumatology outpatient clinic, Santiago Dantas, Carvalho,
Viana, and Fontenele10 found that 86.7% of patients who  were
hospitalized had up to 5 years of diagnosis. Assisi and Baak-
lini (2009)11 stressed that the survival of patients with SLE has
increased in recent decades, thanks to earlier diagnoses and
the use of medications.
The use of less than ﬁve medications may be critical for
QoL. The same number was obtained by Santos (2009)12; these
authors showed that the number of medications ranged from
one to 15, with a mean of 5.09 ± 2.48. This amount of medi-
cations is justiﬁed by Borba et al. (2008)13; in their view, the
maintenance of drug therapy in inactive patients reduces the
possibility of a new outburst of activity, improves their lipid
proﬁle and reduces the risk of thrombosis.
Patients who had their disease controlled showed a higher
Independence level, with signiﬁcance for mobility and quality
of life facets. Patients with active disease had higher scores in
environmental domain, for physical safety and security facet.
Human problems can contextualize the mismatch between
the needs of the individual and the physical and social
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Table 4 – Comparison of quality of life domains and facets (WHOQOL-100) related to disease state – active or inactive, City
of Maringa.
Domains/facets Disease state pa
Active (n = 23) Inactive (n = 36)
Mean SD Mean SD
Physical health 11.7 1.2 12.9 2.9  0.4940
Pain and discomfort 14.3 0.6 12.9 3.7 0.5198
Energy and fatigue 8.7 5.7 12.4 3.9 0.1290
Sleep and rest 16.7 3.1 15.0 4.0 0.4945
Psychological 12.4 1.0 13.6 2.4 0.4041
Positive feelings 14.0 2.7 15.1 2.8 0.5195
Thinking, learning, memory and concentration 14.0 1.0 13.7 3.1 0.8768
Self-esteem 13.0 1.0 14.4 2.9 0.4027
Body image and appearance 9.0 1.7 12.7 3.5 0.0815
Negative feelings 12.0 2.7 12.1 2.9 0.9635
Independence level 10.3 3.8 13.0 2.8 0.1311
Mobility 10.0 5.6 14.8 3.8 0.0463b
Activities of daily living 10.0 6.2 14.0 3.6 0.0895
Dependence on medicinal substances and medical aids 15.0 1.0 15.6 4.0 0.8043
Work capacity 12.3 5.1 14.8 3.8 0.3099
Social relations 15.4 1.3 15.2 2.7  0.8534
Personal relationships 15.7 1.5 15.5 2.8 0.2569
Social support 17.0 2.7 16.1 3.0 0.6065
Sexual activity 13.7 4.9 13.9 4.0 0.9189
Environment 14.0 0.6 14.4 2.0 0.7575
Physical safety and security 15.3 1.2 12.4 1.8 0.0093b
Home environment 15.0 1.7 15.5 2.6 0.7635
Financial resources 12.7 1.2 13.3 3.4 0.7734
Health and social care: availability and quality 13.0 1.7 14.4  2.4 0.3371
Opportunities to acquire new information and skills 16.0 1.0 15.3 3.2 0.6951
Participation in. and opportunities for recreation/leisure 11.7 4.2 13.9 3.5 0.2906
Physical environment: (pollution/noise/trafﬁc/climate) 12.0 2.7 13.7 2.7 0.3011
Transportation 16.3 2.5 16.6 3.2 0.8953
Spiritual aspects/spirituality/religion/personal beliefs 16.7 1.2 17.1 2.5 0.7627
Quality of life from the point of view of the evaluated subject 11.0 3.6 14.7 2.5 0.0199b
SD, standard deviation.
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b Signiﬁcant considering a signiﬁcance level of 5%.
nvironment. The perception of the environmental dimen-
ion depends on a hierarchy of values and this is an individual
rocess, but it reﬂects the current conditions of collective life
nd its impact on the lives of women analyzed in this study.
omen with active SLE had worse QoL in physical, psycho-
ogical and environmental domains. In SLE patients with an
ntensely active disease, it was observed a worse condition of
oL versus women with inactive SLE.1
Thumboo and Strand (2007)14 found that patients with SLE
how major deﬁciencies in functional status compared to the
eneral population, and that the speciﬁc manifestations of
upus (disease activity, prior renal involvement and ﬁbromyal-
ia) can inﬂuence the QoL reported.
Freire et al. (2011)15 suggested that, in many  cases, the
rganic and psychological damage to which patients with SLE
re subject result in physical or mental disability, besides other
rawbacks, worsening QoL, which has been recognized as an
mportant indicator of health for patients with chronic dis-
ases.When referring associated diseases, the patients in this
study indicated that the dependence on medicinal substances
and medical aids facet interferes with QoL. Araújo and
Traverso-Yépez (2007)3 reported that some patients reported
that they no longer had a “normal” life, also admitting with
regret the need “to have to depend on medication for life.”
Medication is the key factor for helping in disease control. The
lack of medication would also be the main detrimental factor
for these patients. However, it is clear that not all participants
make this relationship, when indicating emotional factors as
major contributors to their uncontrolled disease.
Among the negative responses, signiﬁcance was observed
for sexual activity and transportation facets. Silva (2009)16
showed that 4% of women and adult men  with SLE pre-
sented sexual dysfunctions, according to their medical history.
Folomeev and Alekberova (1990)17 identiﬁed a high frequency
of sexual/erectile dysfunction in 35% of men  with SLE.
From a structured interview with adult women, Curry et al.
(1994)18 observed reduced frequency of sexual activity, vaginal
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Table 5 – Comparison of quality of life domains and facets (WHOQOL-100) related to reports of other diseases associated
with SLE, City of Maringa.
Domains/facets Associated diseases pa
Yes (n = 13) No (n = 26)
Mean SD Mean SD
Physical health 11.9 2.7 13.2 2.8  0.1656
Pain and discomfort 14.4 3.0 12.4 3.7 0.5788
Energy and fatigue 10.9 3.3 12.8 4.3 0.1604
Sleep and rest 15.2 4.3 15.2 3.8 0.9999
Psychological 13.1 2.2 13.7 2.4 0.4130
Positive feelings 14.7 2.8 15.2 2.7 0.6282
Thinking, learning, memory and concentration 13.0 3.1 14.1 2.9 0.2688
Self-esteem 14.5 2.1 14.2 3.1 0.7164
Body image and appearance 11.2 2.7 13.0 3.8 0.1355
Negative feelings 12.2 3.0 12.0 2.9 0.8160
Independence level 11.1 2.4 13.6 2.9 0.0102a
Mobility 12.9 3.8 15.3 4.0 0.0790
Activities of daily living 12.2 3.8 14.4 3.9 0.1003
Dependence on medicinal substances and medical aids 17.6 1.7 14.5 4.2 0.0143b
Work capacity 13.1 4.2 15.3 3.6 0.0941
Social relations 14.2 3.0 15.7 2.2  0.0788
Personal relationships 14.9 2.9 15.8 2.7 0.3085
Social support 15.5 3.9 16.4 2.5 0.3922
Sexual activity 12.1 4.5 14.8 3.5 0.0431b
Environment 13.8 1.9 14.6 2.0 0.2570
Physical safety and security 12.3 2.1 12.9 1.8 0.4092
Home environment 14.9 2.1 15.7 2.8 0.3811
Financial resources 12.5 2.9 13.6 3.5 0.3228
Health and social care: availability and quality 13.9 2.2 14.5  2.5 0.5104
Opportunities to acquire new information and skills 14.3 3.4 15.8 2.9 0.1605
Participation in. and opportunities for recreation/leisure 13.9 3.7 13.7 3.5 0.8951
Physical environment: (pollution/noise/trafﬁc/climate) 13.9 2.3 13.4 2.8 0.6088
Transportation 15.1 4.0 17.3 2.3 0.0319b
Spiritual aspects/spirituality/religion/personal beliefs 17.5 2.5 16.9 2.3 0.3995
Quality of life from the point of view of the evaluated subject 13.6 3.0 14.9 2.5 0.1841
SD, standard deviation.
a Non-paired t test.
b Signiﬁcant considering a signiﬁcance level of 5%.
lubrication, and sexual satisfaction in the group with lupus
versus a matched control group.
Silva (2009)16 showed that sexual dysfunction in female
adolescents with lupus is a multifactorial condition and can
occur related to disease activity itself, or by medications such
as corticosteroids and immunosuppressants. The study has
not shown an association between sexual dysfunction and
lupus activity, the cumulative damage caused by disease, or
medication use.
In contrast, Reis (2009)19 assessed satisfaction in the rela-
tionship and affection in the period of exacerbation of the
disease among 74 women with SLE who kept heterosexual
relationship, and noted that those women who had greater
physical intimacy with their partners reported great satisfac-
tion with their relationship; those who avoided or had less
physical intimacy pointed to an intensely negative effect. This
study also revealed the dilemmas faced by women to maintain
intimacy with their partners during disease activity.
Vido and Scanavini (2007)20 emphasized that economic
dependence, discrimination, difﬁculties affecting sexual andreproductive lives and inadequate housing and environmental
conditions are factors that contribute to progressive deteriora-
tion of health, relationships and QoL to those who  experience
SLE.
The transportation referenced by interviewees was charac-
terized by Reis (2009),19 when this author identiﬁed difﬁculties
experienced by women in order to maintain their treatment
and access to care. Transportation was not always guaran-
teed, the distances were large, the travel time lengthy, the
access to speciﬁc medications was poor and the women
had difﬁculty in meeting their requirements for food while
traveling.
Final  considerationsTaking into account the pathology, use of medications and of
other intervening factors on quality of life, in this study we
obtained a good index of quality of life among the interview-
ees. Most women were satisﬁed with their lives and showing
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ptimism, with acceptance of their limitations and enjoying
hat is best for them in their life, seeking in their family
nd personal beliefs forces for the challenges that the disease
mposes.
It was demonstrated that women with SLE may have a
ood QoL, should they take advantage of specialized medical
are. With an effective treatment, the disease remains inac-
ive, providing security to patients and resulting in emotional
ontrol, decreased pain and improvement in other symptoms
nd in improved expectations, meaning that it is possible to
et on well with the disease, culminating with a good quality of
ife.
As to limitations of this study, we can mention the fact that
LE patients completed the instruments used in this study in
he waiting room of the medical ofﬁce; this fact could imply
n concentration difﬁculties to answer the questionnaires.
nother limitation relates to the instrument used which, by
eing lengthy and repetitive, could be tiring for the women.
he origin of patient care can be a weak point of this study.
ue to the number of respondents, it was not possible to strat-
fy the subjects in a group with public unit care and in another
roup with private health care. Further studies with speciﬁc
roups, according to unit type, are suggested.
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